Defective Medications and Bad DrugsConsumers typically place a high level of trust and faith in their physicians. When your physician prescribes a drug, it is common to trust such a recommendation without thinking twice. In fact, a belief that the physician has your best medical interests at heart is generally the reason why you will blindly accept such advice without researching the particular medication. Unfortunately, sometimes doctors prescribe medications or treatments that have debilitating side effects. Normally, the doctor is unaware of the dangers that these defective medical treatments pose to the patient. That ignorance is not limited to the medical professionals who actually treat patients with medication either. In a never-ending rush to bring new drugs to the market, pharmaceutical giants often fail to perform exhaustive tests on new drugs. Often testing is rushed and overlooked by the FDA, resulting in failures to recognize dangerous side-effects. Further, we generally do not know of the long-term results and effects of using many newer medications and treatments. It is not uncommon for profit driven pharmaceutical giants to withhold information pertaining to side effects and long-term issues pertaining to a medication before bringing such to market. The FDA must demand testing and approve a drug before it is made available to consumers. However, the FDA is usually unaware of the long-term effects of medications before they are granted approval. Thus, many physicians who prescribe medications based on FDA approval, are being misled to believe that they are helping patients. In fact, we often do not learn of a drug’s serious side effects or how it interacts with other medications until years later; only after it becomes newsworthy by causing death or serious injury to a number of victims. The damage caused by defective medications often results in permanent serious physical injuries or emotional damage. In fact, unsafe pharmaceutical drugs can result in a stroke, heart attack, pulmonary embolism, degradation of bones, and other issues that will cause an overall diminution of an individual's quality of life. Other defective medications cause damage to the reproductive organs, brain, and endocrine (hormones) system. At Dolman Law Group, we define a bad drug as a medication whose harm outweighs its potential benefit. If you have been physically harmed as a result of a medication, call the bad drug lawyers of the Dolman Law Group at: (727) 451-6900 for a free consultation and case evaluation. We are currently evaluating claims related to:
- Actos: this is a diabetes treatment medication that has been linked to an increased risk of bladder cancer. FDA Actos Warning. Long-term users of this defective drug are at risk.
- Fosamax: this and other osteoporosis treating medications known as bisphosphonates present a risk of bone weakening to long-term users. Dangers include a rare, debilitating condition call osteonecrosis (bone death), commonly of the jaw. The FDA warns of this danger but has yet to issue a recall of bisphosphonates. New York Times article on Fosamax and other Bisphosphonates
- GranuFlo: a concentrated dry acid product used in hemodialysis for diabetics and other victims of acute renal failure. The FDA recalled GranuFlo and the liquid counterpart NaturaLyte after an internal document produced and distributed by the defective product’s maker,Fresenius, was uncovered. The document showed that patients treated with GranuFlor were six to eight times more likely to suffer cardiopulmonary arrest and sudden cardiac death immediately following the treatment. See the full GranuFlo Defective Product memo here.
- Humira: Humira is an injectable drug approved by the FDA for the treatment of inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, Chron’s disease and ulcerative colitis. Humira is a member of a class of drugs called tumor necrosis factor (TNF) inhibitors. Tumor necrosis factor is a protein occurring naturally within the human body that is capable of killing tumor cells.
- Mirena: a contraceptive device designed to be inserted into the uterus by a physician, where it stays implanted for up to five years. Since its approval in 2000, the FDA has received over 45,000 reports of adverse effects of the device including vaginal bleeding, dislocation of the device and uterine perforation. Read more about Mirena birth control complications on our blog.
- Nuvaring: a contraceptive device that has been linked with blood clots, heart attacks, strokes, and other life-threatening conditions. Makers of this defective device arguably failed to warn of the dangerous side-effects caused by the product since it began being prescribed in 2001.
- Pradaxa: this blood thinner was recently approved by the FDA amid a host of studies linking the medication to increased risk and severity of viral sicknesses. Additionally, reports of severe gastrointestinal bleeding and intracranial hemorrhage (brain bleeds) have surfaced with patients being treated by Pradaxa and its predecessor Warfarin.
- Risperdal: an antipsychotic medication used to treat schizophrenia, bipolar disorder, and irritability associated with Autism in children. While these uses are approved by the FDA today, the drug was not approved for use in children when it was originally released in 1993. Despite that restriction, the drug’s manufacturers Ortho-McNeil-Janssen (a subsidiary of Johnson & Johnson) marketed the drug for uses in children. Years later, some children who were prescribed Risperdal for treatment of mental disorders began to experience serious side effects associated with the drug- particularly gynecomastia (male breast growth).
- Yaz: another contraceptive medication that is taken oral and has been tied to an increased risk of blood clots and cardiac damage than the older alternatives. A synthetic hormone used in this and similar defective medications causes increased potassium levels that can lead to heart attack in even younger women. Is it worth the risk?
- Zithromax: a very commonly-used antibacterial medication that is used to treat a range of bacterial infections. An FDA warning was issued on March 12, 2013, describing the danger this medication poses to the patients. This defective drug can cause abnormal changes to the electrical activity of the heart and may potentially cause fatal heart attacks. A link to the recent FDA warning.
Transvaginal Mesh Complications: A transvaginal mesh is a surgically implanted device that was expected to assist with that condition. However, the Food and Drug Administration (FDA) indicates that reports of potentially life-altering complications from transvaginal mesh patches are increasing at an alarming rate.